Linda B. Huber

Linda Huber uses her biochemistry background and patent experience to represent medical and academic institutions, private foundations and medical device and pharmaceutical companies in intellectual property matters.

What do you focus on?

I focus on prosecuting biotechnology and life sciences patents, counseling clients on their patent portfolios and prosecution strategies, conducting due diligence of patent portfolios in corporate transactions and patent license agreements and advising clients on patent related license provisions.

Patent Prosecution

Particular areas I focus on include cancer therapeutics, gene therapy, stem cells, gastrointestinal diseases, inflammatory conditions, neurological diseases, diagnostics and nutritional products.

Client Counseling

Through my understanding of my clients’ needs and goals, I develop and implement strategies to manage and expand their patent portfolios. I also help them understand the implications of licensing terms.

What do you see on the horizon?

I believe that the Federal Circuit will refine the definition of patent-eligible subject matter in favor of patentees.


  • “The New World in US Biotech,” The Chartered Institute of Patent Attorneys Webinar, March 2016
  • “Biotech Claims Drafting,” The Chartered Institute of Patent Attorneys Seminar, October 2014


  • “License Lessons: Don’t overlook key elements in patent-related licensing agreements,” GC California, Nov./Dec. 2009. (Co-author)


Linda B. Huber


Los Angeles

Phone: 213-629-6163

Fax: 877-646-5596

University of San Diego School of Law, J.D., cum laude

University of California, Los Angeles, B.S., Biochemistry


U.S. Patent and Trademark Office

Back to top